UniQure NV - Company Profile
Powered by
All the data and insights you need on UniQure NV in one report.
$295
- Save hours of research time and resources with
our up-to-date UniQure NV Strategy Report
- Understand UniQure NV position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on UniQure NV’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
22 Jun 2021 | uniQure to Acquire Corlieve Therapeutics | Acquisition |
UniQure NV
|
Corlieve Therapeutics SAS
|
01 Mar 2021 | uniQure to Raise up to USD200 Million in Public Offering of Shares | Equity Offering | - |
UniQure NV |
24 Jun 2020 | CSL Behring Enters into Licensing Agreement with uniQure | Licensing Agreement |
CSL Behring LLC
|
UniQure NV |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer